Literature DB >> 31268818

Virtual Elimination of Nephrogenic Systemic Fibrosis: A Medical Success Story with a Small Asterisk.

Matthew S Davenport1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31268818     DOI： 10.1148/radiol.2019191158

Source DB:  PubMed          Journal:  Radiology        ISSN： 0033-8419            Impact factor:   11.105


× No keyword cloud information.
  3 in total

1.  Risk for Nephrogenic Systemic Fibrosis After Exposure to Newer Gadolinium Agents: A Systematic Review.

Authors:  Joseph Lunyera; Dinushika Mohottige; Anastasia-Stefania Alexopoulos; Hilary Campbell; C Blake Cameron; Nicole Sagalla; Timothy J Amrhein; Matthew J Crowley; Jessica R Dietch; Adelaide M Gordon; Andrzej S Kosinski; Sarah Cantrell; John W Williams; Jennifer M Gierisch; Belinda Ear; Karen M Goldstein
Journal:  Ann Intern Med       Date:  2020-06-23       Impact factor: 25.391

2.  Group II GBCM Can Be Used Safely for Imaging in Stage 4/5 CKD Patients: PRO.

Authors:  Roger A Rodby
Journal:  Kidney360       Date:  2020-12-03

Review 3.  Use of Intravenous Gadolinium-Based Contrast Media in Patients With Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation.

Authors:  Jeffrey C Weinreb; Roger A Rodby; Jerry Yee; Carolyn L Wang; Derek Fine; Robert J McDonald; Mark A Perazella; Jonathan R Dillman; Matthew S Davenport
Journal:  Kidney Med       Date:  2020-11-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.